Uses of Bruton's tyrosine kinase inhibitors
TW202629176APending Publication Date: 2026-07-16TRANSTHERA SCIENCES (NANJING) INC
View PDF 0 Cites 0 Cited by
Patent Information
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- TRANSTHERA SCIENCES (NANJING) INC
- Filing Date
- 2025-10-27
- Publication Date
- 2026-07-16
Abstract
This invention belongs to the field of pharmaceutical technology, specifically relating to the use of the compound of formula (I) or its pharmaceutically acceptable salts, isomers or crystal forms in the preparation of medicaments for the prevention or treatment of B-cell malignancies.
Need to check novelty before this filing date? Find Prior Art